Cost-effectiveness of the non-pneumatic anti-shock garment (NASG): evidence from a cluster randomized controlled trial in Zambia and Zimbabwe

Table 5 Costs and clinical resources, by NASG timing group and country

Costs and clinical resources	All women			Zimbabwe			Zambia
	832 women in 38 clusters			305 women in 12 clusters			527 women in 12 clusters
	Late	Early	p-value	Late	Early	p-value	Late	Early	p-value
1. Number of women	466	366		139	166		327	200
2. Proportion of women who received any blood transfusions	36.1%	27.9%		7.9%	5.8%		48.0%	61.0%
3. Mean cost of blood transfusions (of those who received blood)	$114.88	$115.49	0.967	$500.91	$441.25	0.667	$87.83	$94.14	0.240
4. Proportion of women who received any uterotonics	78.8%	78.4%		82.0%	82.5%		77.4%	75.0%
5. Mean cost of uterotonics (of those who received uterotonics)	$4.53	$7.42	<0.001	$13.46	$14.85	0.332	$0.52	$0.64	< 0.001
6. Mean cost per woman	$52.61	$54.56	0.765	$58.30	$41.14	0.275	$50.19	$65.70	< 0.001
	(43.6 - 61.6)	(45.6 - 63.5)		(31.3 - 85.2)	(23.9 - 58.3)		(44.2 - 56.2	(57.8 - 73.5)

Note: Wilcoxon Rank Sum test utilized to test all continuous variables due to non-normality.

ISSN: 1472-6963